Christophe Corpechot

16.0k citations

115 papers · 7.9k indexed · 3 hit papers · h-index 37

Hepatology top 0.1%
- Liver Diseases and Immunity 89
- Liver Disease and Transplantation 22
- Liver physiology and pathology 7
Epidemiology top 0.5%
- Liver Disease Diagnosis and Treatment 75
- Hepatitis B Virus Studies 8
Neurology top 0.5%
Immunology and Allergy top 1%
Surgery top 1%
- Pediatric Hepatobiliary Diseases and Treatments 37
Pulmonary and Respiratory Medicine
- Gallbladder and Bile Duct Disorders 24
Oncology
- Drug Transport and Resistance Mechanisms 8

Co-authors: Olivier Chazouillères Raoul Poupon Yves Chrétien Dominique Wendum Fabrice Carrat Gideon M. Hirschfield Pietro Invernizzi Christoph Schramm
Cited by: Hepatology Epidemiology Neurology
Partner nations: France Italy United Kingdom

In The Last Decade

Christophe Corpechot

103 papers receiving 7.8k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2017 EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis
1997 Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients
1996 Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia

Peers

Countries citing papers authored by Christophe Corpechot

Since Specialization

Citations

This map shows the geographic impact of Christophe Corpechot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Corpechot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Corpechot more than expected).

Fields of papers citing papers by Christophe Corpechot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Corpechot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Corpechot. The network helps show where Christophe Corpechot may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Christophe Corpechot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christophe Corpechot Line = papers co-authored together Christophe Corpechot links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	PBC-HOPE: A Randomized Controlled Trial of Hypnosis and Psychoeducation in Women With Primary Biliary Cholangitis and Fatigue Aurélie Untas,Cécile Goffette,Cécile Flahault,Christel Vioulac,Olivier Chazouillères,(unknown),Karima Ben Belkacem,Farid Gaouar,Nathalie Bernard,Alexandra Rousseau,Christophe Corpechot	2025	0
2	Epidemiology, comorbidities, treatments and outcomes of autoimmune liver diseases: A French nationwide study Christophe Corpechot,Pierre Hornus,M J Cals,Pierre Rinder,Théo Marcille,Amina Malek,Karima Ben Belkacem,Farid Gaouar,Yasmina Chabane,Pierre-Antoine Corret,Paola Squarzoni,Pierre‐Antoine Soret,Sara Lemoinne,O. Chazouillères,Angela Leburgue	2025	0
3	Alkaline Phosphatase Changes With Seladelpar Across Subgroups Of Primary Biliary Cholangitis Patients In The Response Trial Kris Kowdley,Kidist Yimam,Sumit Kumar,Elisabet Mena,Alan Bonder,Kessendri Reddy,Christophe Corpechot,Stephen F. Carroll,Franco Frigerio,Ke Yang,Daria B. Crittenden,Charles A. McWherter	2025	0
4	Comparative effectiveness of peroxisome proliferator–activated receptor agonists as second-line therapies for primary biliary cholangitis: A systematic review and network meta-analysis Adrielly Martins,Nidah S. Khakoo,Anish Reddy,John Reynolds,Christophe Corpechot,Alexandra Rousseau,Mohammed Murad,Shahnaz Sultan,Cynthia Levy	2025	2
5	Recurrence of autoimmune liver diseases after liver transplantation: Review and expert opinion statement Aldo J. Montaño‐Loza,Christophe Corpechot,Patrizia Burra,Christoph Schramm,Nazia Selzner,Vincenzo Ronca,Ye Htun Oo	2024	4
6	Quantitative magnetic resonance cholangiopancreatography metrics are associated with disease severity and outcomes in people with primary sclerosing cholangitis Nora Cazzagon,S. El Mouhadi,Quentin Vanderbecq,Carlos Ferreira,Sarah L. Finnegan,Sara Lemoinne,Christophe Corpechot,Olivier Chazouillères,Lionel Arrivé	2022	15
7	Non-invasive diagnosis and follow-up of primary biliary cholangitis Christophe Corpechot,Alexandra Heurgué,Florence Tanné,Pascal Potier,Bertrand Hanslik,Marie Decraecker,Victor de Lédinghen,Nathalie Ganne‐Carrié,Christophe Bureau,Marc Bourlière	2021	5
8	Association of bezafibrate with transplant-free survival in patients with primary biliary cholangitis Atsushi Tanaka,Junko Hirohara,Toshiaki Nakano,Kosuke Matsumoto,Olivier Chazouillères,Hajime Takikawa,Bettina E. Hansen,Fabrice Carrat,Christophe Corpechot	2021	71
9	Predictive criteria of response to endoscopic treatment for severe strictures in primary sclerosing cholangitis Nora Cazzagon,Olivier Chazouillères,Christophe Corpechot,S. El Mouhadi,Edouard Chambenois,B Desaint,Ulriikka Chaput,Sara Lemoinne,Lionel Arrivé	2019	7
10	Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis Sara Lemoinne,Astrid Kemgang,Karima Ben Belkacem,Marjolène Straube,Sarah Jégou,Christophe Corpechot,(unknown),Olivier Chazouillères,Chantal Housset,Harry Sokol	2019	146
11	Large‐scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis Géraldine Dahlqvist,Farid Gaouar,Fabrice Carrat,Sofia Meurisse,Olivier Chazouillères,Raoul Poupon,Catherine Johanet,Christophe Corpechot	2016	77
12	Liver Steatosis Assessed by Controlled Attenuation Parameter (CAP) Measured with the XL Probe of the FibroScan: A Pilot Study Assessing Diagnostic Accuracy M. Sasso,Stéphane Audière,Astrid Kemgang,Farid Gaouar,Christophe Corpechot,Olivier Chazouillères,Céline Fournier,Olivier Golsztejn,Stéphane Prince,Y. Menu,Laurent Sandrin,Véronique Miette	2015	108
13	Utility of Noninvasive Markers of Fibrosis in Cholestatic Liver Diseases Christophe Corpechot	2015	13
14	Baseline Values and Changes in Liver Stiffness Measured by Transient Elastography Are Associated With Severity of Fibrosis and Outcomes of Patients With Primary Sclerosing Cholangitis Christophe Corpechot,Farid Gaouar,Ahmed El Naggar,Astrid Kemgang,Dominique Wendum,Raoul Poupon,Fabrice Carrat,Olivier Chazouillères	2014	196
15	Early primary biliary cirrhosis: Biochemical response to treatment and prediction of long-term outcome Christophe Corpechot,Olivier Chazouillères,Raoul Poupon	2011	276
16	Hépatites auto-immunes : actualités diagnostiques et thérapeutiques Christophe Corpechot,Olivier Chazouillères	2010	8
17	The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis Christophe Corpechot,Fabrice Carrat,Abbas Bahr,Yves Chrétien,R Poupon,Raoul Poupon	2005	261
18	Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA‐treated patients with primary biliary cirrhosis Christophe Corpechot,Armelle Poujol‐Robert,Dominique Wendum,Marie Galotte,Yves Chrétien,Renée E. Poupon,Raoul Poupon	2004	33
19	Hepatocyte Growth Factor and c-Met Inhibition by Hepatic Cell Hypoxia Christophe Corpechot,Véronique Barbu,Dominique Wendum,Nicolas Chignard,Chantal Housset,Raoul Poupon,Olivier Rosmorduc	2002	65
20	The Effect of Ursodeoxycholic Acid Therapy on Liver Fibrosis Progression in Primary Biliary Cirrhosis Christophe Corpechot,Fabrice Carrat,Anne-Marie Bonnand,Renée E. Poupon,Raoul Poupon,(unknown),(unknown)	2000	222

About Christophe Corpechot

Christophe Corpechot is a scholar working on Hepatology, Epidemiology and Surgery, having authored 115 papers that have together received 7.9k indexed citations. Recurring topics across this work include Liver Diseases and Immunity (89 papers), Liver Disease Diagnosis and Treatment (75 papers), Pediatric Hepatobiliary Diseases and Treatments (37 papers), Gallbladder and Bile Duct Disorders (24 papers), Liver Disease and Transplantation (22 papers), Drug Transport and Resistance Mechanisms (8 papers), Hepatitis B Virus Studies (8 papers) and Liver physiology and pathology (7 papers). The work is most often cited by research in Hepatology (4.8k citations), Epidemiology (4.1k citations) and Neurology (1.5k citations). Christophe Corpechot has collaborated with scholars based in France, Italy and United Kingdom. Frequent co-authors include Olivier Chazouillères, Raoul Poupon, Raoul Poupon, Yves Chrétien, Dominique Wendum, Fabrice Carrat, Gideon M. Hirschfield, Pietro Invernizzi, Christoph Schramm and Chantal Housset.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact